Kelch-like Protein-11 Encephalitis Associated With Squamous Cell Carcinoma of Unknown Origin
A Case Report
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives We report a case of Kelch-like protein-11 (KLHL11) encephalitis associated with squamous cell carcinoma (SCC) of unknown origin in the neck.
Methods A 70-year-old man, diagnosed with prurigo nodularis 4 months prior, presented with subacute-onset progressive dysarthria, imbalance, and diplopia. Neurologic examination revealed horizontal and downbeating nystagmus with lateral gaze, dysarthria, dysmetria, and hearing difficulties. Skin examination showed localized pruritus with excoriated ulcerations on the neck and proximal upper extremities. MRI of the brain revealed T2 hyperintensities in the pons and left cerebellum, and CT of the neck showed a right neck mass.
Results Extensive workup for acquired brainstem syndromes revealed KLHL11 antibodies in both the serum and CSF, together with superimposed unclassified antibodies. The patient was diagnosed with KLHL11 encephalitis and was treated with intravenous immunoglobulin, intravenous methylprednisolone, and plasmapheresis. He underwent right neck dissection, with pathology revealing SCC of unknown origin. Subsequently, the patient received monthly IV cyclophosphamide and adjuvant radiation therapy. His clinical symptoms, including the excoriated ulcerations, improved remarkably with treatment.
Discussion Our patient represents the first case of KLHL11 encephalitis associated with SCC of unknown origin in the neck, and our observations delineate a potentially novel correlation between the 2 diseases.
Footnotes
↵* These authors contributed equally to this work as cofirst authors.
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
Submitted and externally peer reviewed. The handling editor was Deputy Editor Kathryn Kvam, MD.
- Received July 24, 2023.
- Accepted September 26, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.